Candida Arthritis: Analysis of 112 Pediatric and Adult Cases

Author:

Gamaletsou Maria N.123,Rammaert Blandine45,Bueno Marimelle A.1,Sipsas Nikolaos V.23,Moriyama Brad6,Kontoyiannis Dimitrios P.7,Roilides Emmanuel38,Zeller Valerie9,Taj-Aldeen Saad J.10,Miller Andy O.1311,Petraitiene Ruta1,Lortholary Olivier34,Walsh Thomas J.1311

Affiliation:

1. Weill Cornell Medicine of Cornell University, Departments of Medicine, Pediatrics, and Microbiology & Immunology, New York, New York

2. National and Kapodistrian and University of Athens, Greece

3. Center for Osteoarticular Mycoses, Hospital for Special Surgery, New York, New York

4. Université Paris-Descartes, Sorbonne Paris Cité, Assistance Publique Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Centre d'Infectiologie Necker-Pasteur, Institut Imagine

5. Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France

6. Department of Pharmacy, National Institutes of Health Clinical Center, Bethesda, Maryland

7. MD Anderson Cancer Center, Houston, Texas

8. 3rd Department of Pediatrics, Aristotle University School of Health Sciences and Hippokration General Hospital, Thessaloniki, Greece

9. Osteoarticular Reference Center, Groupe Hospitalier Diaconesses-Croix Saint-Simon, Paris, France

10. Mycology Laboratory, University of Doha, Qatar

11. Hospital for Special Surgery, New York, New York

Abstract

Abstract Background.  Candida arthritis is a debilitating form of deeply invasive candidiasis. However, its epidemiology, clinical manifestations, management, and outcome are not well understood. Methods.  Cases of Candida arthritis were reviewed from 1967 through 2014. Variables included Candida spp in joint and/or adjacent bone, underlying conditions, clinical manifestations, inflammatory biomarkers, diagnostic imaging, management, and outcome. Results.  Among 112 evaluable cases, 62% were males and 36% were pediatric. Median age was 40 years (range, <1–84 years). Most patients (65%) were not pharmacologically immunosuppressed. Polyarticular infection (≥3 joints) occurred in 31% of cases. Clinical manifestations included pain (82%), edema (71%), limited function (39%), and erythema (22%) with knees (75%) and hips (15%) most commonly infected. Median erythrocyte sedimentation rate was 62 mm/hr (10–141) and C reactive protein 26 mg/dL (0.5–95). Synovial fluid median white blood cell count was 27 500/µL (range, 100–220 000/µL) with 90% polymorphonuclear neutrophils (range, 24–98). Adjacent osteomyelitis was present in 30% of cases. Candida albicans constituted 63%, Candida tropicalis 14%, and Candida parapsilosis 11%. Most cases (66%) arose de novo, whereas 34% emerged during antifungal therapy. Osteolysis occurred in 42%, joint-effusion in 31%, and soft tissue extension in 21%. Amphotericin and fluconazole were the most commonly used agents. Surgical interventions included debridement in 25%, irrigation 10%, and drainage 12%. Complete or partial response was achieved in 96% and relapse in 16%. Conclusion.  Candida arthritis mainly emerges as a de novo infection in usually non-immunosuppressed patients with hips and knees being most commonly infected. Localizing symptoms are frequent, and the most common etiologic agents are C albicans, C tropicalis, and C parapsilosis. Management of Candida arthritis remains challenging with a clear risk of relapse, despite antifungal therapy.

Funder

Scholar of the Save Our Sick Children Foundation

Sharp Family Foundation

Special Account for Research Funds

National and Kapodistrian University of Athens

National Institutes of Health

MD Anderson Cancer Center

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Questioning the 14‐day dogma in candidemia treatment duration;Mycoses;2023-11-03

2. Management of Fungal Osteoarticular Infections;Current Fungal Infection Reports;2023-02-15

3. Mimics of Synovial Tumors Due to Chronic Infection;Imaging of Synovial Tumors and Tumor-like Conditions;2023

4. Candida Species;Principles and Practice of Pediatric Infectious Diseases;2023

5. Osteoarticular Mycoses;Clinical Microbiology Reviews;2022-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3